Attentional improvement following quetiapine fumarate treatment in schizophrenia

Schizophrenia Research

Volumn 33, Issue 3, 1998, Pages 151-155

  Sax, K W ^a   Strakowski, S M ^a   Keck Jr , P E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Attentional functioning; Schizophrenia; Treatment

Indexed keywords

HALOPERIDOL; QUETIAPINE;

ADULT; ATTENTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; SCHIZOPHRENIA; TASK PERFORMANCE;

EID: 0032500624     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00067-X     Document Type: Article

References (8)

1. Arvanitis, L.A., Miller, B.G., the Seroquel Trial 13 Study Group1997. Multiple fixed doses of seroquel' (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo. Biol. Psychiatry 42, 233-246.
2. Cassens, G., Inglis, A.K., Appelbaum, P.S., Gutheil, T.G., 1990. Neuroleptics: Effects on neuropsychological function in chronic schizophrenic patients. Schizophr. Bull. 16, 477-499.
3. Nuechterlein, K.H., 1991. Vigilance in schizophrenia and related disorders. In: Steinhauer, S.R., Gruzelier, J.H., Zubin, J. (Eds.), Handbook of Schizophrenia, Vol. 5: Neuropsychology, Psychophysiology, and Information Processing. Elsevier Science, Amsterdam, pp. 397-433.
4. Nuechterlein, K.H., Dawson, M.E., Ventura, J., Miklowitz, D., Konishi, G., 1991. Information-processing anomalies in the early course of schizophrenia and bipolar disorder. Schizophr. Res. 5, 195-196.
5. Overall, J.E., Gorham, D.R., 1962. The brief psychiatric rating scale. Psychol. Rep. 10, 799-812.
6. Serper, M.R., Chou, J.C.Y., 1997. Novel neuroleptics improve attentional functioning in schizophrenic patients: Ziprasidone and aripiprazole. CNS Spectrums 2, 56-59.
7. Serper, M.R., Davidson, M., Harvey, P.D., 1994. Attentional predictors of clinical change during neuroleptic treatment in schizophrenia. Schizophr. Res. 13, 65-71.
8. Spitzer, R.L., Williams, J.B., Gibbon, M., First, M.G., 1990.. Structured Clinical Interview for DSM-III-R Patient Edition (SCID-P). Biometrics Research Department, New York State Psychiatric Institute, NY.